ABSCIENCES (EPA:AB) AB SCIENCE - Conversion of preferred shares
Transparency directive : regulatory news
10/09/2010 19:45
Click here to download pdf version
General shareholders' meetingParis, 10 September 2010 at 7.45pm
Conversion of preferred shares
A general meeting and a special meeting of AB Science shareholders were held on
8 September 2010, under the chairmanship of Alain Moussy, CEO of the Company.
The shareholders voted inter alia for the conversion of all 432,000 preferred
shares " P" into ordinary shares. These new ordinary shares will belong to the
same category and will be similar to the shares already traded on NYSE Euronext
Paris SA (Compartment B - ISIN code FR 0010557264). The Company has requested
the listing of these new ordinary shares for trading on the NYSE Euronext Paris
market. This listing should be effective as of 15 September 2010. As a result,
the total number of shares accepted for trading on NYSE Euronext Paris SA will
be increased from 29,925,850 to 30,357,850.
About AB Science
Founded in 2001, AB Science is a pharmaceutical company specializing in the
research, development and commercialization of protein kinase inhibitors
(PKIs), a new class of targeted molecules whose action is to modify signalling
pathways within cells. Through these PKIs, the Company targets diseases with
high unmet medical needs (cancer, inflammatory diseases and central nervous
system diseases), in both human and veterinary medicines. Thanks to its
extensive research and development capabilities, AB Science has its own
portfolio of molecules. masitinib, a lead compound, has already been registered
in veterinary medicine in Europe and is in the middle of three on-going phases
3 in human medicine in pancreatic cancer, GIST and mastocytosis.
More information on AB Science's website: www.ab-science.com
AB Science - Financial Communication & Press Relations
Agnès Villeret - Tel: +33 (0)1 53 32 78 95 - agnes.villeret@citigate.fr
ABSCIENCES's latest news
15/05/2024 20:16
13/03/2024 12:58
07/03/2024 15:20
06/03/2024 20:21
29/02/2024 11:49
26/02/2024 18:32
28/11/2023 19:22
27/11/2023 08:04
29/09/2023 19:49
18/09/2023 18:05
Other stories
16/05/2024 20:30
16/05/2024 18:51
16/05/2024 19:02
16/05/2024 14:37
16/05/2024 18:45
16/05/2024 13:30
16/05/2024 17:12
16/05/2024 18:42
16/05/2024 17:05
16/05/2024 18:03
16/05/2024 17:52
16/05/2024 15:05
16/05/2024 18:44
16/05/2024 13:40
16/05/2024 20:25
Former Post Office executive tells Horizon inquiry she blocked Paula Vennells’ number - The Guardian
16/05/2024 15:29
16/05/2024 17:50
16/05/2024 13:37
16/05/2024 16:07
16/05/2024 08:00
16/05/2024 12:13
16/05/2024 13:42
16/05/2024 18:00
16/05/2024 12:19
16/05/2024 18:53
16/05/2024 06:00
16/05/2024 17:38
16/05/2024 20:47
16/05/2024 13:55
16/05/2024 19:17
15/05/2024 22:40
16/05/2024 18:19
15/05/2024 11:19
16/05/2024 09:24
16/05/2024 10:02
16/05/2024 10:15
16/05/2024 15:24
15/05/2024 19:40